Top Story

Efficacy of VTE chemoprophylaxis in otolaryngology patients varied by subgroup

October 24, 2014

The efficacy and safety of venous thromboembolism chemoprophylaxis for individuals undergoing otolaryngologic surgery varied based on Caprini risk score and the type of surgical procedure required, according to results of a retrospective cohort study.

Patients with high Caprini risk scores, as well as those undergoing microvascular free tissue transfer, appeared to benefit the most, results showed.

figure Meeting News Coverage

ACG president addresses improved prevention, detection, treatment in IBD cancers

October 24, 2014
PHILADELPHIA — At the ACG Annual Scientific Meeting, the incoming president of the college covered cancer in the setting of ulcerative colitis, including…
In the Journals

Recombinant Factor VIII product increased inhibitor development risk

October 24, 2014
One recombinant Factor VIII product was associated with an increased risk for inhibitor formation compared with similar products for the treatment of severe hemophilia…
In the Journals

Tumor characteristics influenced impact of adjuvant radiotherapy in prostate cancer

October 23, 2014
Tumor characteristics considerably influenced the impact of adjuvant radiotherapy on survival outcomes in patients with node-positive prostate cancer, according to study…
More News Headlines »
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
figure

Nomogram predicted recurrence risk among women who underwent APBI

September 26, 2014
Jessica Wobb, MD, senior resident in radiation oncology at Beaumont Health System in Birmingham, Mich., describes how…
More »
CME
figure

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »